MIT researchers have developed a groundbreaking method for gene editing that significantly reduces errors, making gene therapy safer and more effective for treating genetic diseases. This innovative approach promises a future of precise genomic alterations with fewer side effects.
Researchers at Microsoft uncovered a potential biological zero-day vulnerability in DNA screening systems, warning that AI-designed toxins could slip through unnoticed. This groundbreaking study explores the implications for biosecurity and suggests urgent updates to screening protocols.
A team of scientists proposes a bold plan to combat Lyme disease on Nantucket by genetically engineering mice to be immune, raising both hope and ecological concerns in the community.
Texas-based Colossal Biosciences is making strides in their ambitious project to genetically engineer a version of the extinct dodo bird. With advances in cell culturing, experts are excited yet skeptical about the implications of such efforts on conservation.
David Baltimore, a renowned scientist and former president of Caltech, passed away at 87. His groundbreaking research and leadership transformed biology and higher education, leaving a lasting legacy.
Prepare for an exhilarating launch as NASA and SpaceX send 5,000 pounds of vital supplies and groundbreaking experiments to the International Space Station. Tune in for live coverage!
Discover how researchers at IBM and Moderna have leveraged quantum computing to predict the complex protein structure of mRNA, marking a significant advancement in vaccine technology.
Scientists have developed a groundbreaking 'disease-on-a-chip' model for ALS using stem cells, paving the way for potential new treatments. This innovative approach mimics early disease stages and could revolutionize ALS research.
In a stunning move, the FDA has put clinical trials for Sarepta's gene therapy on hold due to alarming safety concerns after multiple patient deaths linked to acute liver failure. The company faces scrutiny as it navigates the fallout.
In a surprising turn, ultra-wealthy family offices are ramping up investments in biotechnology and entertainment, signaling a shift in investment strategies. Learn about the latest deals and why patience is key in biotech.
